| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 1060817-67-5 | | 3-methyl-4-oxo-3,4-dihydro-7-quinazolinecarboxylic acid | C10H8N2O3 | 204.18 | | |
| 1060817-68-6 | | 3-(2-bromo-4-methylphenyl)-1,3-oxazolidin-2-one | | | | |
| 1060817-70-0 | | 5-bromo-4-methyl-2-(4h-1,2,4-triazol-4-yl)pyridine | | | | |
| 1060817-72-2 | | methyl-(4-methyl-[1,2,3]thiadiazol-5-ylmethyl)-amine | | | | |
| 1060817-73-3 | | 3-bromo-2-methyl-6-(4h-1,2,4-triazol-4-yl)pyridine | | | | |
| 1060817-75-5 | | 5-(3-methyl-5-isoxazolyl)-2-furansulfonyl chloride | | | | |
| 1060817-77-7 | | 3-[(2-furylmethyl)thio]-1-propanamine | | | | |
| 106083-71-0 | 盐酸羟基安非他酮 | (2S,3S)-hydroxybupropion hydrochloride | C13H19Cl2NO2 | 292.2 | | |
| 106084-88-2 | | 4-(3-buten-1-ynyl)-1-methyl-4-piperidino hydrochloride | | | | |
| 106086-11-7 | | 3,4-thiazolidinedicarboxylic acid, 2-phenyl-, 3-(1,1-dimethylethyl) ester, sodi | | | | |
| 106086-12-8 | | 3-thiazolidinecarboxylic acid, 4-(((2,5-dioxo-1-pyrrolidinyl)oxy)carbonyl)-2-ph | | | | |
| 106086-14-0 | | 3-thiazolidinecarboxylic acid, 4-(aminocarbonyl)-2-phenyl-, 1,1-dimethylethyl e | | | | |
| 106086-15-1 | 叠氮化物 | 3,4-thiazolidinedicarboxylic acid, 2-phenyl-, 3-(1,1-dimethylethyl) ester, 4-hy | | | | |
| 106086-20-8 | | 2-phenyl-4-thiazolidinecarboxamid monohydrochloride | | | | |
| 106086-21-9 | | 4-thiazolidinecarboxylic acid, 2-phenyl-, hydrazide, monohydrochloride | | | | |
| 106086-22-0 | | n-hexyl-2-phenyl-4-thiazolidinecarboxamid monohydrochloride | | | | |
| 106086-23-1 | | butanoic acid, 4-(((2-phenyl-4-thiazolidinyl)carbonyl)amino)-, methyl ester, mo | | | | |
| 106086-24-2 | | n(sup 2),n(sup 6)-bis((2-phenyl-4-thiazolidinyl)carbonyl)-l-lysin methyl es | | | | |
| 106086-25-3 | | n-(2-mercaptoethyl)-2-phenyl-4-thiazolidinecarboxamid monohydrochloride | | | | |
| 106086-78-6 | | 2-(bromomethyl)-1,3-benzothiazole | C8H6BrNS | 228.11 | 46-51°C | |
| 106087-08-5 | | 3-amino-1-methyl-1-phenyl-4,5-dihydro-1h-pyrazol-1-ium, iodide | | | | |
| 106087-29-0 | | (1,2,4)triazino(3,4-f)purine-6,8(7h,9h)-dione, 1,4-dihydro-3,9-dimethyl-1-ethyl | | | | |
| 106087-30-3 | | 2,4)triazino(3,4-f)purine-6,8(7h,9h)-dione, 1,4-dihydro-3,4,9-trimethyl-( | | | | |
| 106087-31-4 | | 2,4)triazino(3,4-f)purine-6,8(7h,9h)-dione, 1,4-dihydro-1,3,4,9-tetramethyl-( | | | | |
| 106087-32-5 | | (1,2,4)triazino(3,4-f)purine-6,8(7h,9h)-dione, 1,4-dihydro-1-phenyl-3,4,9-trime | | | | |
| 106087-35-8 | | (1,2,4)triazino(3,4-f)purine-6,8(7h,9h)-dione, 1,4-dihydro-3-ethyl-9-methyl-1-p | | | | |
| 106087-36-9 | | benzoic acid, 4-(6,8-dioxo-9-methyl-3-phenyl-1,4,6,7,8,9-hexahydro-(1,2,4)-tria | | | | |
| 106087-38-1 | | 9-methyl- | | | | |
| 106087-39-2 | | 2,4)triazino(3,4-f)purine-6,8(7h,9h)-dione, 1,4-dihydro-1-ethyl-9-methyl-7-( | | | | |
| 106087-41-6 | | (1,2,4)triazino(3,4-f)purine-6,8(7h,9h)-dione, 1,4-dihydro-1,7-bis(piperidinome | | | | |
| 106087-42-7 | | (1,2,4)triazino(3,4-f)purine-6,8(7h,9h)-dione, 1,4-dihydro-1,7-bis(morpholinome | | | | |
| 106087-44-9 | | thyl)-9- methyl-3-phenyl- | | | | |
| 106087-45-0 | | 9- dimethyl-3-phenyl-thyl)- | | | | |
| 106089-20-7 | | (S)-3-bromo-2-hydroxy-2-methylpropionic acid | C4H7BrO3 | 183 | 113-114 °C | 294.5±25.0 °C(Predicted) |
| 106089-24-1 | (2R)-1-(2-methylprop-2-enoyl)pyrrolidine-2-carboxylic acid | | C9H13NO3 | 183.2039 | | |
| 106092-09-5 | (S)-(-)-2,6-二氨基-4,5,6,7-四氢苯并噻唑 | (S)-(-)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole | C7H11N3S | 169.25 | 222-224°C | |
| 106092-11-9 | (+)-(6R)-2,6-二氨基-4,5,6,7-四氢苯并噻唑 | (+)-(6R)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole | C7H11N3S | 169.25 | 228-230 °C | 359.0±42.0 °C(Predicted) |
| 106094-47-7 | (3-氟金刚烷-1-基)甲醇 | (3-Fluoroadamantan-1-yl)methanol | C11H17FO | 184.25 | | |
| 106094-83-1 | | 2-amino-7-(bis(2-chloroethyl)amino)-1,2,3,4-tetrahydro-2-naphthoic acid | | | | |
| 106095-27-6 | | 3-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenoxy)-3-buten-2-on h | | | | |
| 106095-45-8 | | 1-methyl-2-(3-methyl-pent-2-enyl)-cyclohexane | C13H24 | 180.33 | | |
| 106096-92-8 | | fibroblast growth factor | | | | |
| 106096-93-9 | | fibroblast growth factor, basic, recombinant human, kcb-1 | | | | |
| 1060980-53-1 | 8-甲基-3,4-二氢-1h-吡啶并[4,3-b]吲哚-2(5h)-羧酸叔丁酯 | tert-butyl 8-methyl-3,4-dihydro-1h-pyrido[4,3-b]indole-2(5h)-carboxylate | | | | |
| 1061-06-9 | | 2h-1,4-benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-phenyl-1-(2-(1-pyrrolidinyl) | | | | |
| 1061-20-7 | | 2h-1,4-benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-phenyl-1-(2-piperidinoethyl) | | | | |
| 1061-21-8 | | 2h-1,4-benzodiazepin-2-one, 1,3-dihydro-7-chloro-1-(2-morpholinoethyl)-5-phenyl | | | | |
| 1061-54-7 | | (3b)-spirost-5-en-3-yl acetate | | | | |
| 1061-73-0 | | 2-(p-(5,6-dimethoxy-2-phenyl-3-indenyl)phenoxy)-triethylamin hydrochloride | | | | |
| 1061-86-5 | | 4-[(7-chloro-1-oxido-4-quinolinyl)amino]-2-{[decyl(methyl)amino]methyl}phenol | | | | |
m.cnreagent.com